Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
69 participants
INTERVENTIONAL
2016-04-30
2016-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Behavior of Infants Fed Formula Supplemented With Prebiotics
NCT02757924
Formula Tolerance of Term Infants
NCT04915937
Growth and Tolerance of Young Infants Fed Infant Formula
NCT04105686
Tolerance of Healthy Term Infants Fed Infant Formulas #3
NCT00977964
Tolerance of Healthy Term Infants Fed Infant Formulas
NCT00705562
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Infant Formula supplemented with Oligosaccharides
Ready to feed infant formula ; Feed ad libitum.
Infant Formula supplemented with Oligosaccharides
sole source nutrition
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Infant Formula supplemented with Oligosaccharides
sole source nutrition
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is a singleton full-term birth with a gestational age of 37 - 42 weeks
* Subject's birth weight was ≥ 2490 g (\~5 lbs. 8 oz.)
* Subject is between 7 and 42 days of age
* Infant was identified by parents as very fussy or extremely fussy in the baseline tolerance evaluation
* Infant is exclusively formula-fed at time of study entry
* Parent(s) confirm their intention not to administer vitamin or mineral supplements, solid foods or juices to their infant from enrollment through the duration of the study
* Subject's parent(s) has voluntarily signed and dated an informed consent form (ICF) prior to any participation in the study
Exclusion Criteria
* Subject is taking and plans to continue medications, home remedies, herbal preparations or rehydration fluids that might affect gastrointestinal (GI) tolerance
* Subject participates in another study that has not been approved as a concomitant study
* Subject has been fed any formula containing human milk oligosaccharides prior to study enrollment
* Subject has been treated with oral antibiotics within 7 days prior to study enrollment
* Mother intends to use a combination of breast and formula feeding
7 Days
42 Days
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marlene Borschel, PhD, RD
Role: STUDY_CHAIR
Abbott Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama, United States
Southeastern Pediatric Associates
Dothan, Alabama, United States
Watching Over Mothers and Babies
Tucson, Arizona, United States
Norwich Pediatric Group, PC
Norwich, Connecticut, United States
Florida Institute for Clinical Research, LLC
Orlando, Florida, United States
Score Physician Alliance, LLC
St. Petersburg, Florida, United States
Women's Clinic of Lincoln, PC
Lincoln, Nebraska, United States
Institute of Clinical Research, LLC
Cleveland, Ohio, United States
Aventiv Research
Grove City, Ohio, United States
Coastal Pediatric Research
Charleston, South Carolina, United States
DCOL Center for Clinical Research
Longview, Texas, United States
Southwest Children's Research Associates, P.A.
San Antonio, Texas, United States
Tanner Clinic
Layton, Utah, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AL19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.